G. G. Bain Metropolitan Opera baritone Giuseppe De Luca, New York 1920
• 100,000 deaths broached in the US.
New cases past 24 hours in:
• US + 19,582
• Brazil + 17,838
• Russia + 8,915
• UK 4,938
• India + 6,604
• Peru + 5,772
BREAKING: Coronavirus Outbreak
We added Mongolia (see recent tweet) to our Winners circle. Zero transmissions ever! All cases were imported with caution. Not accidental: They did everything. Congratulations!
— Yaneer Bar-Yam (@yaneerbaryam) May 26, 2020
We’re back to “normal” numbers: about 100,000 new cases and 4,500 new deaths.
• Cases 5,709,518 (+ 99,864 from yesterday’s 5,609,654)
• Deaths 352,750 (+ 4,428 from yesterday’s 348,322)
From Worldometer yesterday evening -before their day’s close- Note: see bottom 2: Pakistan passed Belgium in cases, but has 5 deaths per million pop. vs Belgium’s 806.
Capitalism at its peak.
Desperation for the limited supply of remdesivir is so great that Virginia will hold a lottery to determine which of the almost 1,500 severely ill patients in the state will be able to get its several hundred donated doses of the drug. In Minnesota, state officials have come up with an action plan to allocate their supply of the Covid-19 treatment, which calls for designating “triage officers” who will randomly choose among equally eligible patients. And in Alabama, physicians on a coronavirus task force set up by the governor will determine which patients get remdesivir. Some hospitals there will receive just a single course of treatment. Still, Alabama’s state health officer, Dr. Scott Harris, recently offered his thanks to Gilead, the drug’s manufacturer, which donated some 940,000 vials of the drug to the federal government that are being distributed by state health departments.
“Although the total supply of remdesivir is limited, we are grateful that hospitalized COVID-19 patients with severe disease in Alabama can receive this potentially lifesaving medication,” said Harris. It is amid these feelings of scarcity and indebtedness that Gilead is setting the price for its antiviral medicine. The company, which has already arranged for distribution of remdesivir in 127 countries, is expected to begin selling it commercially as soon as June. And while a 10-day course of the drug, which was developed as a potential Ebola treatment with at least $79 million in U.S. government funding, costs only about $10 to produce, according to an estimate by the Institute for Clinical and Economic Review, its market price is expected to be several hundred times that amount.
Still, price gouging isn’t what has many scientists upset about remdesivir. It’s the fact that the coronavirus drug that has boosted hopes and sent Gilead’s stock price (and according to some analysts, the entire stock market) soaring doesn’t seem to do much for coronavirus patients. said William Haseltine, a scientist who has spent decades studying viruses and helped lead the U.S. government response to the HIV/AIDS epidemic. “It is comparable to Tamiflu and maybe not even as good,” Haseltine added, referring to another antiviral drug that has been available by prescription for 20 years and is expected to be sold over the counter in the coming months.
Haseltine, who founded the divisions of biochemical pharmacology and human retrovirology at Harvard University’s School of Public Health, pointed out that Gilead hasn’t released data showing remdesivir’s effect on viral load in people with Covid-19. Meanwhile, the only available information on how the drug affects the amount of the coronavirus in patients, a Chinese study of the drug published in The Lancet, showed that the drug did not lower the viral load. “That’s why I call it the fuzzy-wuzzy drug,” said Haseltine. “When the Chinese tried to find the antiviral effect, it wasn’t there.” Instead, the excitement about remdesivir is based largely on a study sponsored by the National Institute of Allergy and Infectious Diseases that showed people taking the drug had a faster recovery than those who didn’t take it: 11 days on average compared to 15 for those taking a placebo.
An article published on May 22 in the New England Journal of Medicine showed mild improvement in hospitalized patients that took remdesivir, though the drug didn’t appear to be of any help to the sickest patients, who needed to receive high-flow oxygen through ventilators or other means. Nor did the drug significantly improve a patient’s chance of surviving Covid-19. Nevertheless, at an April 29 Oval Office press conference with President Donald Trump, NIAID Director Dr. Anthony Fauci declared that preliminary results from that trial proved that “a drug can block this virus.” Since then, remdesivir has been positioned as our savior and Gilead as its benevolent dispenser.
While some patients and their families have spent the past few weeks frantically trying to procure remdesivir, another Covid-19 treatment has been quietly been shown to be more effective. Although neither option appears to be the much-needed cure for Covid-19, a three-drug regimen offered a greater reduction in the time it took patients to recover than remdesivir did. People who took the combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin got better in seven days as opposed to 12 days for those who didn’t take it. Critically, the treatment has another leg up on Gilead’s: It clearly reduced the amount of the coronavirus in patients who took it, according to a study published in The Lancet on May 8.
Yet so far there has been no stampede of patients demanding the new regimen or lotteries to mete out the doses, which may be due at least in part to the fact that the treatment hasn’t been the subject of a major marketing campaign. It’s worth noting that each of the three drugs in the new combination is generic, or no longer under patent, which means that no company stands to profit significantly from its use.
We’d want to see all the other research from the past 65 years as well, please.
The World Health Organization (WHO) on Tuesday promised a swift review of data on hydroxychloroquine, probably by mid-June, after safety concerns prompted the group to suspend the malaria drug’s use in a large trial on COVID-19 patients. U.S. President Donald Trump and others have pushed hydroxychloroquine as a coronavirus treatment, but the WHO on Monday called time after the British journal The Lancet reported patients getting hydroxychloroquine had increased death rates and irregular heartbeats. “A final decision on the harm, benefit or lack of benefit of hydroxychloroquine will be made once the evidence has been reviewed,” the body said. “It is expected by mid-June.”
Those already in a 17-country study, called Solidarity, of thousands of patients who have started hydroxychloroquine can finish their treatment, the WHO said. Newly enrolled patients will get other treatments being evaluated, including Gilead Science’s remdesivir and AbbVie’s Kaletra/Aluvia. Separate hydroxychloroquine trials, including a 440-patient U.S. study by Swiss drugmaker Novartis, are continuing enrollment. Novartis and rival Sanofi have pledged donations of tens of millions of doses of the drug, also used in rheumatoid arthritis and lupus, for COVID-19. Novartis said The Lancet study, while covering 100,000 people, was “observational” and could not demonstrate a causal link between hydroxychloroquine and side effects. “We need randomised, controlled clinical trials to clearly understand efficacy and safety,” a Novartis spokesman said.
You can’t do accurate testing for antibodies if too small a segment of a population is infected.
Antibody tests used to determine if people have been infected in the past with Covid-19 might be wrong up to half the time, the US Centers for Disease Control and Prevention said in new guidance posted on its website. Antibody tests, often called serologic tests, look for evidence of an immune response to infection. “Antibodies in some persons can be detected within the first week of illness onset,” the CDC says. They are not accurate enough to use to make important policy decisions, the CDC said. “Serologic test results should not be used to make decisions about grouping persons residing in or being admitted to congregate settings, such as schools, dormitories, or correctional facilities,” the CDC says.
“Serologic test results should not be used to make decisions about returning persons to the workplace.” Health officials or health care providers who are using antibody tests need to use the most accurate test they can find and might need to test people twice, the CDC said in the new guidance. “In most of the country, including areas that have been heavily impacted, the prevalence of SARS-CoV-2 antibody is expected to be low, ranging from less than 5% to 25%, so that testing at this point might result in relatively more false positive results and fewer false-negative results,” the CDC said.
[..] The CDC explains why testing can be wrong so often. A lot has to do with how common the virus is in the population being tested. “For example, in a population where the prevalence is 5%, a test with 90% sensitivity and 95% specificity will yield a positive predictive value of 49%. In other words, less than half of those testing positive will truly have antibodies,” the CDC said. “Alternatively, the same test in a population with an antibody prevalence exceeding 52% will yield a positive predictive greater than 95%, meaning that less than one in 20 people testing positive will have a false positive test result.”
While just 15 have seen cases fall for 14 days.
Twenty U.S. states reported an increase in new cases of COVID-19 for the week ended May 24, up from 13 states in the prior week, as the death toll from the novel coronavirus approaches 100,000, according to a Reuters analysis. Alabama had the biggest weekly increase at 28%, Missouri’s new cases rose 27% and North Carolina’s rose 26%, according to the analysis of data from The COVID Tracking Project, a volunteer-run effort to track the outbreak. New cases in Georgia, one of the first states to reopen, rose 21% after two weeks of declines. The state attributed the increase to a backlog of test results and more testing. Nationally, new cases of COVID-19 fell 0.8% for the week ended May 24, compared with a decline of 8% in the prior week.
All 50 states have now at least partially reopened, raising fears among some health officials of a second wave of outbreaks. The increase in cases could also be due to more testing. The Centers for Disease Control and Prevention (CDC) has recommended states wait for their daily number of new COVID-19 cases to fall for 14 days before easing social distancing restrictions. As of May 24, 15 states had met that criteria, up from 13 in the prior week, according to the Reuters analysis. Washington state, where the U.S. outbreak started, has the longest streak with cases falling for eight weeks in a row, followed by Hawaii at seven weeks and Pennsylvania and New York at six weeks.
Viruses don’t use strategies. That’s just another absurdity provoked by all the war comparisons. How can you be at war with something that’s not even considered alive? You might as well declare war on a rock or a mountain, or the sky, the ocean.
The vast majority of people alive in the west today have no first hand experience of war, and neither do the politicians who speak to them in terms of war. What makes them feel comfortable with the language, then? Is it Hollywood?
The novel coronavirus uses the same strategy to evade attack from the human immune system as HIV, according to a new study by Chinese scientists. Both viruses remove marker molecules on the surface of an infected cell that are used by the immune system to identify invaders, the researchers said in a non-peer reviewed paper posted on preprint website bioRxiv.org on Sunday. They warned that this commonality could mean Sars-CoV-2, the clinical name for the virus, could be around for some time, like HIV. Virologist Zhang Hui and a team from Sun Yat-sen University in Guangzhou also said their discovery added weight to clinical observations that the coronavirus was showing “some characteristics of viruses causing chronic infection”.
Their research involved collecting killer T cells from five patients who had recently recovered from Covid-19, the disease caused by the virus. Those immune cells are generated by people after they are infected with Sars-CoV-2 – their job is to find and destroy the virus. But the killer T cells used in the study were not effective at eliminating the virus in infected cells. When the scientists took a closer look they found that a molecule known as major histocompatibility complex, or MHC, was missing. The molecule is an identification tag usually present in the membrane of a healthy cell, or in sick cells infected by other coronaviruses such as severe acute respiratory syndrome, or Sars. It changes with infections, alerting the immune system whether a cell is healthy or infected by a virus.
Coronavirus spread would dramatically drop if 80% of a population wore masks – AI researcher
Zhong Nanshan again, who said in late January that the epidemic in Wuhan would be over in 10 days. That was spoken as a Beijing mouthpiece, and that’s what he still is.
The US death toll from the coronavirus pandemic has shocked the scientist leading the fight against the disease in China, with the respiratory disease expert attributing the magnitude of American fatalities to a failure by policymakers to heed scientists’ advice. More than 1.66 million Covid-19 infections have been reported in the US, with 98,226 people dying from the disease – the highest number of deaths for any country. In all, 5.49 million people have been infected globally and more than 340,000 have died, according to Johns Hopkins University. “Seventeen years ago, the Sars epidemic was handled so well in the US, completely differently from the situation now,” said Zhong Nanshan, director of the National Clinical Research Centre for Respiratory Disease and the leader of a team of scientists advising the government.
“You can say that [the US] carried out very extensive screening or more screening than other countries … But the heavy casualties still shocked me,” he said in an exclusive interview with the South China Morning Post. Zhong said his counterparts in the US told him that the American system was ill-prepared for the epidemic, despite the country’s high level of medical care, equipment and facilities. He said this was similar to the early response in Wuhan – the central Chinese city where the outbreak was first identified – when many medical personnel were infected and died. But the main problem in the US was the failure to listen to medical experts, he said. As a result, US President Donald Trump “underestimated the disease’s infectious power as well as its harmful nature. He thought it was a big flu.
US officials also did not listen to medical experts’ views concerning the reopening of the economy, he said. “Opening the economy quickly can be risky. I think they should follow the rules of science and reopen the economy step by step,” Zhong said. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, has cautioned against businesses reopening too soon because of the threat of a second wave of infections. Fauci, who is the government’s top medical specialist, has said repeatedly that “the virus will decide when the country is to open back up”.
Do explain, Justin. Tell us how you do not see elderly people as disposable. See, there’s no way you never saw a single complaint before the virus came.
Canadian troops deployed to long-term care homes overwhelmed by coronavirus outbreaks found neglected and malnourished residents, rotten food and insect infestations, and a blatant disregard for critical safety protocol, according to a bombshell report from the country’s armed forces. Military medics were dispatched to long-term care facilities in Quebec and Ontario in late April, with aim of blunting Covid-19 outbreaks among vulnerable populations. Soldiers deployed to five of Ontario’s worst-hit care homes encountered rotten food, cockroaches and residents in soiled diapers, according to the report published on Tuesday. At one facility, residents had not been bathed in weeks. At another, staff made “derogatory or inappropriate comments directed at residents’”.
Neglect of resident hygiene and health, often leading to infection, was documented at all facilities. At one point, “patients [were] observed crying for help with staff not responding for 30 mins to over two hours,” the report said. [..] Long-term care homes in Canada, many of which are privately run, have been hit the hardest by the pandemic, with residents making up nearly eight out of 10 Covid-19-related deaths across the country. The damage has been felt most acutely in Ontario and Quebec, which have the vast majority of the country’s coronavirus cases and fatalities. An estimated 225 people died at the five homes where the military was assisting in Ontario.
The report chronicled widespread “burnout” among staff, a number of whom hadn’t seen family in weeks. The military also found numerous examples of staff showing little knowledge of how to properly wear personal protective equipment when dealing with coronavirus cases. [..] Meanwhile, the Canadian military said today that some 36 members working in long-term care homes in Ontario and Quebec have become sick with Covid-19.
A French care home is helping families meet and hold each other again inside a plastic ‘happiness bubble’ pic.twitter.com/HdPnkwjFqA
— Reuters (@Reuters) May 27, 2020
In 2018, hospitals, nursing homes, and their lobbyists gave $2.3 million to New York governor Andrew Cuomo’s political apparatus. Now health care executives are getting immunity for their deadly negligence during the coronavirus pandemic. Critics say New York’s liability shield is linked to higher nursing-home death rates during the pandemic.
As Governor Andrew Cuomo faced a spirited challenge in his bid to win New York’s 2018 Democratic primary, his political apparatus got a last-minute boost: a powerful health care industry group suddenly poured more than $1 million into a Democratic committee backing his campaign. Less than two years after that flood of cash from the Greater New York Hospital Association (GNYHA), Cuomo signed legislation last month quietly shielding hospital and nursing-home executives from the threat of lawsuits stemming from the coronavirus outbreak. The provision, inserted into an annual budget bill by Cuomo’s aides, created one of the nation’s most explicit immunity protections for health care industry officials, according to legal experts.
Critics say Cuomo removed a key deterrent against nursing home and hospital corporations cutting corners in ways that jeopardize lives. As those critics now try to repeal the provision during this final week of Albany’s legislative session, they assert that data prove such immunity is correlating to higher nursing-home death rates during the pandemic — both in New York and in other states enacting similar immunity policies. New York has become one of the globe’s major pandemic hot spots — and the epicenter of the state’s outbreak has been nursing homes, where more than five thousand New Yorkers have died, according to Associated Press data.
Those deaths have occurred as Cuomo’s critics say he has taken a hands-off approach to regulating the health care industry interests that helped bankroll his election campaign. In March, Cuomo’s administration issued an order that allowed nursing homes to readmit sick patients without testing them for COVID-19. Amid allegations of undercounted casualties, the governor also pushed back against pressure to have state regulators more stringently record and report death rates in nursing homes. And then came Cuomo’s annual budget — which included a little-noticed passage shielding corporate officials who run New York hospitals, nursing homes, and other health care facilities from liability for COVID-related deaths and injuries.
You think we’ll listen now, listen more, listen better? I predict yes, we will. For two whole weeks.
Coronavirus has ravaged care homes across Europe and America, killing tens of thousands, but in Hong Kong, not a single resident in care has even contracted Covid-19. Its apparent success offers vital lessons – ones that the city learned the hard way almost two decades ago. In Sweden and Belgium, care home residents make up roughly half of each country’s Covid-19 deaths. In Spain alone, almost 18,000 nursing home residents have died from the virus, El País estimates. And in England and Wales, more than 90 per cent of those who have died from the coronavirus have been people over the age of 65, including 12,500 care home residents, according to the Office for National Statistics.
No one would have been surprised if Hong Kong suffered from a major Covid-19 epidemic. It shares a border with mainland China, which is crossed by hundreds of thousands of people every day. Most of the city’s tourists come from the mainland, accounting for tens of millions of visitors every year. In early February, Hong Kong had its first death from coronavirus – only the second death outside of mainland China. But to this day, there have been only four Covid-19 deaths in Hong Kong, a city of 7.5 million. This is not the first time Hong Kong has faced a novel coronavirus. In 2003, six years after the former British colony was handed back to China, it became the epicentre of the SARS outbreak: 299 people died, accounting for almost 40 per cent of the global death toll. The disease had first appeared the year before in Guangdong, the Chinese province that borders Hong Kong.
As is the case with Covid-19, the elderly were the most susceptible to SARS, and similar to the UK, about a fifth of Hong Kong’s population is over the age of 65. By the epidemic’s end, 54 nursing homes had had cases of SARS. Two nursing home workers died. It was not a trauma the industry would quickly forget. “The nightmare of SARS is still on everyone’s minds, so [care homes] were really afraid,” Prof Terry Lum, the head of the department of social work and social administration at the University of Hong Kong, told The Independent. “We had learned a very painful lesson,” he continued, “and since then the nursing homes had been preparing for another outbreak.” Seventeen years after SARS, Hong Kong’s nursing homes were taking no chances.
On 21 January, an infected tourist from Wuhan crossed the border into Hong Kong, becoming the city’s first case. Four days later, the government announced that it would be enacting the emergency phase of its infectious disease protocol. Because of Hong Kong’s collective memory of SARS, individuals, organisations and businesses did not need to wait for instructions from the government. Nursing homes enacted their own measures, Prof Lum recounted. They began limiting the length of workers’ leaves, in order to prevent them from taking weekend trips to mainland China and possibly bringing the virus back. When nursing homes were instructed to take the temperature of all visitors, they took it one step further: they banned visitors altogether, effectively closing off their residents from the outside world by the end of January. There were still only 13 confirmed cases in Hong Kong at the time.
Send your kid to law school. That’s where the money is.
Camping in Scarborough, Maine. Gathering for church in Chincoteague, Virginia. Or just grabbing a burger at Poopy’s Pub and Grub in Savanna, Illinois. Each of these activities became the subject of a federal lawsuit, as residents, businesses and even lawmakers challenged state shutdown orders designed to prevent the spread of novel coronavirus. The cases test where the lines are safely drawn, as governors balance protecting public health against individual liberties. Governors say strict rules save lives, but critics who are forced to stay home or shutter their businesses called the steps “draconian” or compared them to “house arrest.” The lawsuits come as President Donald Trump has become increasingly vocal in criticism of state restrictions, encouraged protests at state capitols and urged churches to reopen despite restrictions.
More than 1,300 state and federal lawsuits have been filed over COVID-19, including 240 dealing with civil rights, as of Friday, according to Hunton Andrews Kurth, a law firm tracking the cases. USA TODAY reviewed more than 80 lawsuits that often dealt with conditions at prisons and nursing homes, voting rights, and university tuition. USA TODAY focused on legal challenges to restrictions such as stay-at-home orders and business closures, and also whether abortion or church services can be limited during the pandemic, to gauge which orders were being challenged and how states were responding. The eventual rulings could redefine the balance between state police powers and constitutional rights that advocates contend are too important to sacrifice even temporarily.
Abortions are time sensitive. Buyers want guns during times of crisis. And parishioners seek solace at church. Other lawsuits test whether rules go beyond legislative authorities by requiring people to isolate themselves, stay apart in public and wear masks. “I tend to think there will be some new law made only because there are new scenarios that courts haven’t encountered before,” said Polly Price, a law professor at Emory University. “What they’re balancing is the scientific basis for a particular measure and the state’s need for it, in the face of uncertainty, to protect the public health.”
CNN and the WaPo as fact-checkers. Oh boy.
No matter what else happens, Twitter just volunteered to go from being a platform to being a publisher. That has consequences.
President Trump on Tuesday night lambasted Twitter because the company slapped a message on two of his tweets that linked to a page disputing the accuracy of his posts. “@Twitter is now interfering in the 2020 Presidential Election. They are saying my statement on Mail-In Ballots, which will lead to massive corruption and fraud, is incorrect, based on fact-checking by Fake News CNN and the Amazon Washington Post,” the president tweeted. “Twitter is completely stifling FREE SPEECH, and I, as President, will not allow it to happen!” he added in another tweet. Twitter labeled two of Trump’s tweets in which he warned that mail-in voting is ripe for fraud—he specifically warned that absue would be committed in California. Democratic California Gov. Gavin Newsom earlier this month signed an executive order for every registered voter to receive mail-in ballots for the November 2020 general election.
“There is NO WAY (ZERO!) that Mail-In Ballots will be anything less than substantially fraudulent. Mail boxes will be robbed, ballots will be forged & even illegally printed out & fraudulently signed. The Governor of California is sending Ballots to millions of people, anyone living in the state, no matter who they are or how they got there, will get one,” President Trump tweeted in a two-tweet series. “That will be followed up with professionals telling all of these people, many of whom have never even thought of voting before, how, and for whom, to vote. This will be a Rigged Election. No way!” Twitter plastered a message on both of Trump’s tweets that says “Get the facts about mail-in ballots.” That message links to a page that pushes back against the president’s assertions.
“On Tuesday, President Trump made a series of claims about potential voter fraud after California Governor Gavin Newsom announced an effort to expand mail-in voting in California during the COVID-19 pandemic,” the page says. “These claims are unsubstantiated, according to CNN, Washington Post and others. Experts say mail-in ballots are very rarely linked to voter fraud.”
Something tells me it will never be enough.
Japan will compile a fresh stimulus package worth $1.1 trillion that will include a sizable amount of direct spending to cushion the economic blow from the coronavirus pandemic, a draft of the budget obtained by Reuters showed on Wednesday. The stimulus, which will be funded partly by a second extra budget, will be on top of a $1.1 trillion package already rolled out last month, putting the total amount Japan spends to combat the virus fallout at 234 trillion yen – roughly 40% of Japan’s GDP. The government’s 117 trillion yen ($1.1 trillion) in fresh stimulus, to be compiled on Wednesday, will include 33 trillion yen in direct spending, the draft showed.
To fund the costs, Japan will issue an additional 31.9 trillion yen in government bonds under the second supplementary budget for the current fiscal year ending in March 2021, according to the draft. “We must protect business and employment by any means in the face of the tough road ahead. We must also take all necessary measures to prepare for another wave of epidemic,” Prime Minister Shinzo Abe said in a meeting with ruling party lawmakers on Wednesday. Government officials have said the new package will include steps such as an increased medical spending, aid to firms struggling to pay rent, support for students who lost part-time jobs, and more subsidies to companies hit by slumping sales. In the second extra budget, the government will also set aside 10 trillion yen in reserves that can be tapped for emergency spending, the draft showed.
Macron comes close to giving away cars for free to save the planet.
President Emmanuel Macron announced an 8 billion euro ($8.8 billion) plan on Tuesday to make France the top producer of clean vehicles in Europe and urged French carmakers to make vehicles in their own country. French car plants are only just starting to rev up production after the coronavirus lockdown, which hit the auto sector badly, and Macron wants to accelerate the transition to electric cars to help revive the industry. “We need a motivational goal: make France Europe’s top producer of clean vehicles by bringing output (up) to more than one million electric and hybrid cars per year over the next five years,” Macron told a news conference. To achieve that goal, he said France would increase the state bonus for consumers buying electric cars to €7,000 euros ($7,690) from €6,000.
But to help dealerships sell the 400,000 vehicles left unsold because of the lockdown, Macron said people buying a traditional car would also receive a €3,000 bonus under a scheme that would apply to three-quarters of households. “Our fellow citizens need to buy more vehicles, and in particular clean ones. Not in two, five or 10 years – now,” Macron said following a visit to a Valeo car parts factory in northern France. No car model currently produced in France should be manufactured abroad, he said. Renault, which produces its Zoe electric model in France, had pledged to make a future Renault-Nissan electric engine in France and not in Asia, as initially envisaged, he said.
It’ll be an extreme election season. Someday a real rain will come and wash all this scum off the streets.
Just 17 days before President Trump took office in January 2017, then-FBI counterintelligence agent Peter Strzok texted bureau lawyer Lisa Page, his mistress, to express concern about sharing sensitive Russia probe evidence with the departing Obama White House. Strzok had just engaged in a conversation with his boss, then-FBI Assistant Director William Priestap, about evidence from the investigation of incoming National Security Adviser Michael Flynn, codenamed Crossfire Razor, or “CR” for short. The evidence in question were so-called “tech cuts” from intercepted conversations between Flynn and Russian ambassador Sergey Kislyak, according to the texts and interviews with officials familiar with the conversations.
[..] The text messages, which were never released to the public by the FBI but were provided to this reporter in September 2018, have taken on much more significance to both federal and congressional investigators in recent weeks as the Justice Department has requested that Flynn’s conviction be thrown out and his charges of lying to the FBI about Kislyak dismissed. U.S. Attorney Jeff Jensen of Missouri (special prosecutor for DOJ), the FBI inspection division, three Senate committees and House Republicans are all investigating the handling of Flynn’s case and whether any crimes were committed or political influence exerted.
The investigators are trying to determine whether Obama’s well-known disdain for Flynn, a career military intelligence officer, influenced the decision by the FBI leadership to reject its own agent’s recommendation to shut down a probe of Flynn in January 2017 and instead pursue an interview where agents might catch him in a lie. They also want to know whether the conversation about the Presidential Daily Briefings involved Flynn and “reporting” the FBI had gathered by early January 2017 showing the incoming national security adviser was neither a counterintelligence nor a criminal threat. “The evidence connecting President Obama to the Flynn operation is getting stronger,” one investigator with direct knowledge told me.
“The bureau knew it did not have evidence to justify that Flynn was either a criminal or counterintelligence threat and should have shut the case down. But the perception that Obama and his team would not be happy with that outcome may have driven the FBI to keep the probe open without justification and to pivot to an interview that left some agents worried involved entrapment or a perjury trap.” The investigator said more interviews will need to be done to determine exactly what role Obama’s perception of Flynn played in the FBI’s decision making. Recently declassified evidence show a total of 39 outgoing Obama administration officials sought to unmask Flynn’s name in intelligence interviews between Election Day 2016 and Inauguration Day 2017, signaling a keen interest in Flynn’s overseas calls.
We try to run the Automatic Earth on people’s kind donations. Since their revenue has collapsed, ads no longer pay for all you read, and your support is now an integral part of the interaction.
‘Wave’ is a virtual art installation that makes it seem like there are real waves inside an enclosed space pic.twitter.com/ydLMQiVxf9
— Reuters (@Reuters) May 27, 2020
And a bit of Dominic Cummings at the end.
If Boris loses the Daily Mail in this fashion, what can he do?
Support the Automatic Earth in virustime.